These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3567152)

  • 1. Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation. Implications for diabetes mellitus.
    Tarsio JF; Reger LA; Furcht LT
    Biochemistry; 1987 Feb; 26(4):1014-20. PubMed ID: 3567152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus.
    Tarsio JF; Wigness B; Rhode TD; Rupp WM; Buchwald H; Furcht LT
    Diabetes; 1985 May; 34(5):477-84. PubMed ID: 3987974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association.
    Tarsio JF; Reger LA; Furcht LT
    Diabetes; 1988 May; 37(5):532-9. PubMed ID: 3360214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished adhesion of endothelial aortic cells on fibronectin and collagen layers after nonenzymatic glycation.
    Krantz S; Lober M; Thiele M; Teuscher E
    Exp Clin Endocrinol; 1988 May; 91(2):155-60. PubMed ID: 3409968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of fibronectin and its gelatin-binding domains with fluorescent-labeled chains of type I collagen.
    Ingham KC; Brew SA; Isaacs BS
    J Biol Chem; 1988 Apr; 263(10):4624-8. PubMed ID: 3127386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the interaction between human plasma fibronectin and collagen by means of affinity electrophoresis.
    Nakamura K; Kashiwagi S; Takeo K
    J Chromatogr; 1992 Apr; 597(1-2):351-6. PubMed ID: 1517338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen.
    Paralkar VM; Nandedkar AK; Pointer RH; Kleinman HK; Reddi AH
    J Biol Chem; 1990 Oct; 265(28):17281-4. PubMed ID: 2211625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components.
    Wallon UM; Overall CM
    J Biol Chem; 1997 Mar; 272(11):7473-81. PubMed ID: 9054449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibronectin binding to matrix components by nonenzymatic glycosylation.
    Cohen MP; Ku L
    Diabetes; 1984 Oct; 33(10):970-4. PubMed ID: 6479461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin.
    San Antonio JD; Slover J; Lawler J; Karnovsky MJ; Lander AD
    Biochemistry; 1993 May; 32(18):4746-55. PubMed ID: 8490019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acylation of gelatin-agarose and the enhancement by heparin of fibronectin binding.
    Smith RL; Griffin CA
    Arch Biochem Biophys; 1988 Oct; 266(1):181-8. PubMed ID: 3178220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between the glomerular basement membrane and fibronectin as revealed by affinity chromatography ].
    Lubec G; Latzka U; Coradello H; Pollak A
    Wien Klin Wochenschr; 1982 May; 94(11):288-90. PubMed ID: 7123957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered proliferation of retinal microvascular cells on glycated matrix.
    Kalfa TA; Gerritsen ME; Carlson EC; Binstock AJ; Tsilibary EC
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2358-67. PubMed ID: 7591625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin type IV collagen interactions: equilibrium binding and inhibition of type IV collagen self-assembly.
    Tsilibary EC; Koliakos GG; Charonis AS; Vogel AM; Reger LA; Furcht LT
    J Biol Chem; 1988 Dec; 263(35):19112-8. PubMed ID: 3198614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal relationship between conformational change and inhibition of domain functions of glycoxidative fibronectin.
    Sakata N; Sasatomi Y; Ando S; Meng J; Imanaga Y; Uesugi N; Takebayashi S
    Connect Tissue Res; 2000; 41(2):117-29. PubMed ID: 10992158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the interaction between human plasma fibronectin and gelatin by affinity electrophoresis.
    Kashiwagi S; Nakamura K; Takeo K; Takasago T; Uchimichi A; Ito H
    Electrophoresis; 1991 Jun; 12(6):420-4. PubMed ID: 1889390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexing of fibronectin glycosaminoglycans and collagen.
    Ruoslahti E; Engvall E
    Biochim Biophys Acta; 1980 Aug; 631(2):350-8. PubMed ID: 7407251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources. Effect of diabetes and age.
    Garlick RL; Bunn HF; Spiro RG
    Diabetes; 1988 Aug; 37(8):1144-50. PubMed ID: 3134265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inaccessibility to ligands of the amino-terminal region of plasma fibronectin.
    Homandberg GA
    Thromb Res; 1987 Nov; 48(3):321-7. PubMed ID: 3433256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of the binding of fibronectin to gelatin reveals the presence of different binding interactions.
    Garcia-Pardo A; Gold LI
    Arch Biochem Biophys; 1993 Jul; 304(1):181-8. PubMed ID: 8323285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.